QuidelOrtho Corp·4

Jun 29, 5:59 PM ET

RHOADS ANN D 4

4 · QuidelOrtho Corp · Filed Jun 29, 2026

Research Summary

AI-generated summary of this filing

Updated

QuidelOrtho (QDEL) Director Ann D. Rhoads Receives RSU Award

What Happened
Ann D. Rhoads, a director of QuidelOrtho Corporation (QDEL), was granted three restricted stock unit (RSU) awards on June 25, 2026 totaling 19,599 RSUs (15,532; 3,698; and 369). Each RSU represents the right to receive one share of common stock; the awards were granted at $0.00 per share (no cash purchase) and are derivative awards that convert to shares upon vesting.

Key Details

  • Transaction date: June 25, 2026; filing date: June 29, 2026 (Form 4) — appears timely (Form 4 is due within 2 business days).
  • Grants: 15,532 RSUs, 3,698 RSUs, and 369 RSUs; grant price reported as $0.00 (award). Total granted = 19,599 RSUs.
  • Vesting / release notes from the filing:
    • F1: Each RSU = right to one share.
    • F2: Some RSUs will vest on June 25, 2027.
    • F3: These RSUs were received in lieu of cash director retainer fees under a deferred compensation program; release of vested RSUs will follow the director’s elected deferral schedule.
    • F4: The 3,698-RSU block vests in four tranches: 924 shares on 6/25/2026, 924 on 9/25/2026, 925 on 12/25/2026, and 925 on 3/25/2027.
  • Shares owned after the transaction: not disclosed in the filing.

Context
RSU awards are compensation-based, not open-market purchases or sales; they don’t necessarily signal immediate trading intent. Because these were issued in lieu of cash retainers and follow a deferral/vesting schedule, the economic benefit to the director depends on future vesting and any elected deferral dates. For retail investors, awards are informative about executive/director pay and potential future share issuance but should not be read as a direct buy/sell endorsement.

Insider Transaction Report

Form 4
Period: 2026-06-25
RHOADS ANN D
Director
Transactions
  • Award

    Restricted Stock Units (Equity Grant)

    [F1][F2]
    2026-06-25+15,53215,532 total
    Common Stock (15,532 underlying)
  • Award

    Restricted Stock Units (Converted)

    [F1][F3][F4]
    2026-06-25+3,6983,698 total
    Common Stock (3,698 underlying)
  • Award

    Restricted Stock Units (Premium)

    [F1][F2][F3]
    2026-06-25+369369 total
    Common Stock (369 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • [F2]The restricted stock units will vest on June 25, 2027.
  • [F3]The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
  • [F4]924 shares vested on June 25, 2026, 924 shares will vest on September 25, 2026, 925 shares will vest on December 25, 2026, and 925 shares will vest on March 25, 2027.
Signature
/s/ Phillip S. Askim, attorney-in-fact for Ann D. Rhoads|2026-06-29

Documents

1 file
  • 4
    wk-form4_1782770364.xmlPrimary

    FORM 4